Role of inflammation and ischemia after implantation of xenogeneic pulmonary valve conduits: Histological evaluation after 6 to 12 months in sheep

International Journal of Artificial Organs

Volumn 26, Issue 5, 2003, Pages 411-420

  Wilhelmi, Mathias H ^a,b   Rebe, P ^b   Leyh, R ^a   Wilhelmi, M ^a   Haverich, A ^a,b   Mertsching, H ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Leibnitz Res Labs Biotech A   (Germany)

Author keywords

Biological heart valve prosthesis; Degeneration; Inflammation; Ischemia; Ovine model; Pulmonary heart valve; Tissue engineering

Indexed keywords

BIOMINERALIZATION; BLOOD VESSELS; HEART; TISSUE; TISSUE ENGINEERING; VALVES (MECHANICAL);

BIOLOGICAL HEART VALVE PROSTHESIS; DEGENERATION; DEGENERATIVE CHANGES; HISTOLOGICAL EVALUATION; ISCHAEMIA; MICROVESSELS; OVINE MODEL; PULMONARY HEART VALVE; PULMONARY VALVES; TISSUES ENGINEERINGS;

PATHOLOGY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST CULTURE; HEART MUSCLE ISCHEMIA; HEART VALVE BIOPROSTHESIS; HISTOLOGY; IN VITRO STUDY; LUNG ARTERY; MICROVASCULATURE; MYOCARDITIS; NONHUMAN; POSTOPERATIVE PERIOD; SHEEP; TISSUE ENGINEERING;

EID: 0038721585     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880302600507     Document Type: Article

References (24)

1. O'Brien MF, McGrifin DC, Stafford EG. Allograft aortic valve replacement: Long-term comparative clinical analysis of the viable cryopreserved and antibiotic 4 degree C stored valves. J Card Surg 1991; 6: 534-43.
2. Pupello DF, Besone LN, Hiro SP, Lopez-Cuenca E, Glatterer MS, Brock JC, Angell WW, Ebra G. Bioprosthetic valve durability in the elderly: Second decade. J Card Surg 1991; 6 (suppl 4): S575-9.
3. Wilson GJ, Courtman DW, Klement P, Lee JM, Yeger H. Acellular matrix: A biomaterials approach for coronary artery bypass and heart valve replacement. Ann Thorac Surg 1995; 60 (suppl): S353-8.
4. Steinhoff G, Stock U, Karim N, et al. Tissue engineering of pulmonary heart valves on allogeneic acellular matrix conduits: In vivo restoration of valve tissue. Circulation 2000; 102 (19 suppl 3): SIII50-55.
5. Hoerstrup SP, Zund G, Schnell AM, Kolb SA, Viisjager JF, Schoeberlein A, Turina M. Optimized growth conditions for tissue engineering of human cardiovascular structures. Int J Artif Organs 2000; 23: 817-23.
6. Kim WG, Cho SK, Kang MC, Lee TY, Park JK. Tissue-engineered heart valve leaflets: An animal study. Int J Artif Organs 2001; 24: 642-8.
7. Shinoka T, Shum-Tim D, Ma PX, et al. Creation of a viable pulmonary artery autograft through tissue-engineering. J Thorac Cardiovasc Surg 1998; 116: 536-46.
8. Harken R, Taylor WJ, LeFemine AA, et al. Aortic valve replacement with a caged ball valve. Am J Cardiol 1962; 9: 202-9.
9. O'Brien MF, Goldstein S, Walsh S, Black KS, Elkins R, Clarke D. The SynerGaraft valve: A new acellular (non-glutaraldehyde-fixed) tissue heart valve for autologous recellularization: First experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 1999; 11 (suppl): S194-200.
10. Fauci AS. The idiopathic hypereosinophilic syndrome: Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982; 97: 78-92.
11. Ferrans VJ, Roberts WC. The carcinoid endocardial plaque. An ultrastructural study. Hum Pathol 1976; 7: 387-409.
12. Rowley KM, Clubb KS, Walker Smith GJ, Cabin HS. Right-sided infective endocarditis as a consequence of flow-directed pulmonary artery catheterisation. A clinicopathological study of 55 autopsied patients. N Engl J Med 1984; 311: 1152-6.
13. Scheld WM. Pathogenesis and pathophysiology of infective endocarditis. In: Sande MA, Kaye D, Root RK, eds. Endocarditis. New York: Churchill Livingston, 1984: 1-32.
14. Oliver RF, Hulme J, Mudie A, Grant RA. Skin collagen allografts in the rat. Nature 1975; 258: 537-9.
15. Pober JS, Collins T, Gimbrone MA, Jr, Libby P, Reiss CS. Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation 1986; 41: 141-6.
16. Clarke DR, Campbell DN, Hayquard AR. Degeneration of aortic valve allografts in young patients. J Thorac Cardiovasc Surg 1993; 105: 934-42.
17. Khatib HE, Lupinetti FM. Antigenicity of fresh and cryopreserved rat valve allografts. Transplantation 1990; 49: 765-7.
18. Lupinetti FM, Christy JP, King D. Immunogenicity, antigenicity, and endothelial viability of aortic valves preserved at 4°C in a nutrient medium. J Card Surg 1991; 6: 454-61.
19. Simon A, Zavazava N, Sievers HH. In vitro cultivation and immunogenicity of human cardiac endothelium. J Card Surg 1993; 8: 656-65.
20. Thiede A, Timm C, Bernhard A. Studies on the antigenicity of vital allergeneic valve leaflet transplants in immunogenetically controlled srain combinations. Transplantation 1978; 391-5.
21. Williams CM, Krajewski CA, Dacher FJ, Ter Haar AM, Santos GW. Host repopulation of endothelium. Transpl Porx 1971; III: 869.
22. Weind KL, Boughner DR, Rigutto L, Ellis CG. Oxygen diffusion and consumption of aortic valve cusps. Am J Physiol Heart Circ Physiol 2001; 281: H2604-11.
23. Weind KL, Ellis CG, Boughner DR. The aortic valve blood supply. J Heart Valve Dis 2000; 9: 1-7.
24. Weind KL, Ellis CG, Boughner. Aortic valve cusp vessel density: Relationship with tissue thickness. J Thorac Cardiovasc Surg 2002; 123: 333-40.